Study details the experimental model and subject details for five cases of isolated PM-ccRCC, including patient inclusion/exclusion criteria, sample transport, processing, and cell culture optimization. The study also covers exome sequencing, mutation and CN analysis, single-cell RNA sequencing, drug sensitivity and resistance testing, immunostainings, pathway analysis, and ethical approvals. Statistical analysis and reproducibility are discussed, with results compared between PM-ccRCC DSRT data and previously published ccRCC DSRT data.